Coronavirus: When will South Africa start vaccinating?

A medical staff member of the South Africa Health Department obtains a nasal swab sample from a passenger in a mobile testing unit at O.R Tambo International Airport in Ekurhuleni on December 30, 3030, where passengers that have COVID-19 symptoms upon arrival are tested. (Photo by Luca Sola / AFP) (Photo by LUCA SOLA/AFP via Getty Images)
South Africa has the highest number of infections in Africa

More than a third of all Covid-19 cases in Africa have been in South Africa and there are growing concerns about the impact of a new variant of the virus.

The country has received its first batch of vaccines, but has halted its rollout because of uncertainty about its effectiveness against the new strain.

What vaccines has South Africa got?

One million doses of the Oxford-AstraZeneca vaccine, produced in India, have now arrived, and another half million are expected later this month.

The first batch needs to undergo various checks before being distributed for use, which is expected to take at least two weeks.

However, South Africa has put the rollout of this vaccine on hold, following a study that showed “disappointing” results against the country’s new Covid-19 strain.

Health care workers and patients outside area Steve Biko Academic Hospital in Pretoria, South Africa.
Health care workers and patients outside area Steve Biko Academic Hospital in Pretoria, South Africa.

South Africa has so far secured a total of twenty million doses, due to be delivered in the first half of 2021, according to President Cyril Ramaphosa.

However, it appears that the bulk of these vaccines won’t be available for several months and there has been criticism that the government has been too slow to act.

Apart from bilateral deals with manufacturers, South Africa is sourcing vaccines from the World Health Organization-backed Covax scheme, as well as through an African Union programme.

Covax is a global initiative in which countries pool their resources to support the development of vaccines with a view to ensure that all countries receive a fair supply of effective vaccines.

South Africa expects to acquire doses for around 10% of the population through Covax and has been told it will receive them from April through to June.

The African Union established the African vaccine acquisition task team last year to source vaccine doses for the continent.

Could South Africa have got vaccines sooner?

There’s been concern that many poorer, less-developed countries are being left behind in the global competition to secure vaccine supplies.

A medical staff member of the South Africa Health Department works at a computer in a mobile testing unit at O.R Tambo International Airport in Ekurhuleni on December 30, 3030, where passengers that have COVID-19 symptoms upon arrival are tested. (Photo by Luca Sola / AFP) (Photo by LUCA SOLA/AFP via Getty Images)
A medical staff member of the South Africa Health Department works at a computer in a mobile testing unit at O.R Tambo International Airport in Ekurhuleni on December 30, 3030, where passengers that have COVID-19 symptoms upon arrival are tested. (Photo by Luca Sola / AFP) (Photo by LUCA SOLA/AFP via Getty Images)

However, critics suggest that South Africa – as the richest country in Africa – should not be in this position.

“The stunning reality is that [South Africa] has neither a secured vaccine supply nor a plan for mass inoculation in the foreseeable future that can withstand scrutiny,” says the Progressive Health Forum, a group of leading medical experts in the country.

The opposition Democratic Alliance has called on the government to give full details of its negotiations with vaccine suppliers, accusing the government of “dropping the ball”.

It claims the government only started to talk to vaccine suppliers in early January.

And it’s also emerged that South Africawill pay more than twice the price for AstraZeneca vaccines than countries in Europe.

What does the government say?

Dr Anban Pillay, deputy director-general at the Ministry of Health, says the country was in touch with manufacturers as far back as last September.

“There have been various conversations through the better part of last year,” says Dr Pillay.

Graphic
Two full doses of the Oxford vaccine gave 62% protection, a half dose followed by a full dose was 90% and overall the trial showed 70% protection.

“The vaccines that most of the other countries have procured are vaccines that may not be ideal for South Africa from various perspectives,” he has said.

He says the Pfizer/BioNTech vaccine wouldn’t be appropriate for mass vaccination, often in remote rural areas, due to its storage requirements of -70C.

And he points out that the ministerial advisory committee advised against using this vaccine.

“We were waiting for the other vaccines that we can use as a mass rollout campaign, and those vaccines had not come through the production line yet,” he said.

He also says some countries have gone ahead with some vaccines without completed clinical trial data, which wouldn’t be allowed by the regulator in South Africa.

The government says it couldn’t have signed deals early without knowing whether the vaccines were safe and effective, as this would have been in contravention of national financial laws.

“In terms of our public funds, we’re required to invest in a product once we understand that the product works,” Dr Pillay says.

What did other countries do?

Wealthy countries, such as the UK and others, signed deals for prospective vaccines as early as July last year while they were still in development and undergoing trials.

And countries who can afford to pay most at the earliest stage of development and production can often secure an advantage, according to experts.

South Africa did take part in a trial for the Oxford-AstraZeneca vaccine starting in July last year,and involving some 2,000 people.

It’s unclear whether or not the authorities used this to begin negotiating for supplies from the manufacturer.

A volunteer receives an injection from a medical worker during the country"s first human clinical trial for a potential vaccine against the novel coronavirus, at Baragwanath Hospital in Soweto, South Africa, June 24, 2020. REUTERS/Siphiwe Sibeko/File Photo
South Africa has been taking part in human trials for several potential Covid-19 vaccines

Research by Duke University in the US tracking advance vaccine commitments by country shows that the majority of doses purchased so far have been for high income countries.

Of the 19 countries which currently have more than a million confirmed coronavirus cases, there are others in addition to South Africa which are yet to start vaccinating, such as Colombia, Peru, Ukraine and Iran.

Banner image reading 'more about coronavirus'
Banner image reading ‘more about coronavirus’
Banner
Banner
Reality Check branding
Reality Check branding

Read more from Reality Check

Send us your questions

source: yahoo.com